Nuvation Bio director granted 123,397 stock options

Nuvation Bio Inc. director Xiangmin Cui reported receiving a stock option grant on Class A common stock.

Rhea-AI Filing Summary

Nuvation Bio Inc. director Xiangmin Cui reported receiving a stock option grant on Class A common stock. The award covers 123,397 options with an exercise price of $4.79 per share and expires on May 20, 2036. Following this grant, Cui holds 123,397 derivative securities linked to the company’s Class A common stock.

According to the terms, 100% of the options will vest on the earlier of May 21, 2026 or the next shareholder annual meeting, provided Cui remains in continuous service through that vesting date. This filing reflects a compensation-related acquisition rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 123,397 shares

Grant/Award 1 txn

Insider Cui Xiangmin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	123,397	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 123,397 contracts (Direct)

Footnotes (1)

1. F1. 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.

Key Figures

Options granted: 123,397 options Exercise price: $4.79 per share Underlying shares: 123,397 shares +3 more

6 metrics

Options granted 123,397 options Stock Option (Right to Buy) grant to director

Exercise price $4.79 per share Exercise price for granted stock options

Underlying shares 123,397 shares Class A Common Stock underlying the options

Expiration date May 20, 2036 Option expiration date

Total derivative holdings after grant 123,397 options Total stock options held following transaction

Vesting date trigger May 21, 2026 100% vesting or earlier next shareholder annual meeting

Key Terms

Stock Option (Right to Buy), Class A Common Stock, vesting, shareholder annual meeting

4 terms

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy) on Class A Common Stock was granted"

Class A Common Stock financial

"underlying security title is Class A Common Stock for the options"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

vesting financial

"100% of the shares subject to the option shall vest on the earlier date"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

shareholder annual meeting financial

"options vest on the earlier of May 21, 2026 or the next shareholder annual meeting"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Nuvation Bio (NUVB) report for Xiangmin Cui?

Nuvation Bio reported a stock option grant to director Xiangmin Cui. Cui received 123,397 stock options on Class A common stock as compensation, rather than buying or selling shares on the open market, reflecting a typical equity-based incentive award for a board member.

How many Nuvation Bio (NUVB) options were granted to director Xiangmin Cui?

Xiangmin Cui was granted 123,397 stock options. These options entitle Cui to purchase up to 123,397 shares of Nuvation Bio’s Class A common stock, subject to vesting conditions tied to time in service and the timing of the next shareholder annual meeting.

What is the exercise price and expiration date of Xiangmin Cui’s NUVB stock options?

The options have a $4.79 exercise price and expire on May 20, 2036. Cui can buy Nuvation Bio Class A common shares at $4.79 per share once vested, any time before the stated 2036 expiration date, subject to the award’s terms and continuous service.

When do the newly granted Nuvation Bio (NUVB) options to Xiangmin Cui vest?

All the options vest on a single future date. 100% of the 123,397 options vest on the earlier of May 21, 2026, or the next shareholder annual meeting, assuming Cui continues to serve with Nuvation Bio through that applicable vesting date.

Did Xiangmin Cui buy or sell Nuvation Bio (NUVB) shares in this Form 4?

No open-market buy or sell occurred in this Form 4. The filing shows a compensation-related acquisition coded as a grant of stock options, rather than a purchase or sale of existing Nuvation Bio common shares in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 08:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cui Xiangmin

(Last) (First) (Middle)

C/O NUVATION BIO INC.

1500 BROADWAY, SUITE 1401

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nuvation Bio Inc. [ NUVB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$4.79	05/21/2026		A		123,397		(1)	05/20/2036	Class A Common Stock	123,397	$0	123,397	D

Explanation of Responses:

1. 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.

	/s/ Stephen Dang, Attorney-in-Fact	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)